John Evans
CEO @Beam Therapeutics
Cambridge, MA, US
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Apr 2017 — Present
CEO @Beam Therapeutics
View department →
Beam Therapeutics is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes. Join Beam’s team of fearless innovators! We are currently hiring for all positions!
SKILLS
Drug DevelopmentCorporate DevelopmentBusiness DevelopmentPharmaceutical IndustryLifesciencesBiotechnologyLife SciencesProduct DevelopmentStrategyOncology
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.